Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Reportlinker Adds Global Disposable Medical Gloves Industry

February 22, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 22, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Disposable Medical Gloves Industry http://www.reportlinker.com/p098378/Global-Disposable-Medical-Gloves-Industry.html This report analyzes the worldwide markets...

Delcath Systems Receives Refusal to File Letter From FDA

February 22, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 22, 2011 /- Delcath Systems, Inc. (Nasdaq: DCTH ) announced today that the Company has received a "refusal to file" letter from the U.S. Food & Drug Administration (FDA) for the New Drug Application (NDA) for its proprietary chemosaturation system used in the treatment...

Enox Biopharma, Inc. to Present at IN3 West Investment in Innovation Conference.

February 22, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

VANCOUVER, British Columbia, Feb. 22, 2011 /- Enox Biopharma, Inc. CEO, John C. Rewcastle, Ph.D., will present at the IN3 West Investment in Innovation Conference on Thursday, February 24 at 11:05 AM PST. The conference is being held at the Venetian Hotel in Las Vegas. Dr. Rewcastle will...

Advertisement

Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional

February 21, 2011 10:36 pm | by Bio-Medicine.Org | News | Comments

NEW BRUNSWICK, N.J. and LEIDEN, Netherlands, Feb. 22, 2011 /- Johnson & Johnson (NYSE: JNJ ) and Crucell N.V. (NYSE Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX) today announce that Johnson & Johnson has completed the tender offer for Crucell N.V. (Crucell) and has declared the...

Acuo Technologies Announces Another Significant Growth Year in Revenue and Implementations to Further the Company's Market Leading Position

February 21, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

BLOOMINGTON, Minn., Feb. 21, 2011 /- Acuo Technologies®, a market leading provider of comprehensive software solutions to the medical imaging industry for archiving, collaboration and migration services, announces another year of significant growth during Fiscal Year 2010. The...

Acuo Technologies Announces New Enterprise Capabilities with Latest Software Release

February 21, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

BLOOMINGTON, Minn., Feb. 21, 2011 /- Acuo Technologies®, a market leading provider of comprehensive software solutions to the medical imaging industry for archiving, collaboration and migration services, is pleased to announce the availability of the latest release of its market...

SuccessEHS Announces its Enterprise Ambulatory EHR Solution for Hospitals

February 21, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

BIRMINGHAM, Ala., Feb. 21, 2011 /- SuccessEHS, a nationally recognized, streamlined practice management and electronic health record (EHR) vendor, has coupled its premier ambulatory care software solution with a signature Success Architecture to meet the ambulatory care needs of...

A Presidential Pardon on Joint Pain

February 21, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

BRADENTON, Fla., Feb. 21, 2011 /- Past presidents such as Gerald Ford, Ronald Reagan, and George H.W. Bush are among the millions of Americans who have undergone some form of joint replacement/repair surgery. While we see presidents come and go, advancements in joint replacement...

Advertisement

Sheffield Bio-Science and Wockhardt Announce Worldwide Exclusive Partnership to Supply Recombinant Insulin to Cell Culture Market

February 21, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

BELOIT, Wis., Feb. 21, 2011 /- Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for...

New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period(2)

February 20, 2011 6:35 pm | by Bio-Medicine.Org | News | Comments

LAWRENCE, Mass. and PHOENIX, Feb. 20, 2011 /- NxStage® Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study which show an increase in overall quality of life benefits,...

Saint Louis U Scientists Partner on Malaria Research

February 18, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Feb. 18, 2011 /PRNewswire-USNewswire/ --  The Center for World Health & Medicine at Saint Louis University and China's Guangzhou Institutes of Biomedicine and Health (GIBH) are forming a global research partnership that initially will focus on new treatments for...

Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles)

February 18, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Feb. 18, 2011 /- Grifols, the Spanish group which specializes in the hospital-pharmaceutical sector and is one of the world's leading producers of plasma products, will shortly start construction of a new plant representing an investment of 20 million euros that will...

Smith & Nephew's Exclusive OXINIUMâ„¢ Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japanese Market

February 18, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn., Feb. 18, 2011 /- OXINIUM™ Oxidized Zirconium, the patented advanced bearing material from Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedics Division, has been awarded a C1 premium reimbursement classification in Japan for use in hip replacement surgery. The...

Advertisement

NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges

February 18, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

ALEXANDRIA, Va., Feb. 18, 2011 /PRNewswire-USNewswire/ -- The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) have sent a joint letter to every Governor and State Medicaid Director, explaining the importance of pharmacies in...

Smith & Nephew Enables Minimally Invasive and Anterior Approach Hip Replacement Surgeries With Launch of Modular, Mini Hip Stem

February 18, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn., Feb. 18, 2011 /- At this week's annual meeting of the American Academy of Orthopedic Surgeons, Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedic Division introduced its Short Modular Femoral (SMF™) Hip System, a modular total hip replacement stem system that...

American Scientific Resources Announces New Distributor HospiServices Placing Kidz-Med VeraTemp in Middle Eastern and African Pharmacies

February 18, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

WESTON, Fla., Feb. 18, 2011 /- American Scientific Resources, Inc. (Pink Sheets: ASFX ) announces Lebanon-based HospiServices is the Company's new distributor in the Middle East and Africa. HospiServices has placed its second order totaling 684 units for the Kidz-Med line of VeraTemp...

Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe

February 18, 2011 3:38 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Feb. 18, 2011 /- Life Technologies Corporation (Nasdaq: LIFE ), today announced Dr. Angel Carracedo and Dr. Mark Pallen as the winners of the European Ion Torrent Personal Genome Machine (PGM™) Sequencer Grants Program.   (Logo:  ...

Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine

February 18, 2011 3:38 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla., Feb. 18, 2011 /- Bellicum Pharmaceuticals, Inc. today announced the presentation of Phase I/II safety and efficacy data for BPX-101, a novel drug-activated dendritic cell vaccine for metastatic castrate resistant prostate cancer (mCRPC), in three separate posters at the...

NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting

February 18, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Feb. 18, 2011 /- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage biopharmaceutical company, today presented the final safety and immunogenicity results from its 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine clinical trial in Mexico at the invitation-only 7th...

Zimmer Announces Early Clinical Success of Zimmer® MotionLoc™ Screw Implantation

February 18, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 18, 2011 /- Zimmer Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a global leader in musculoskeletal care, today announced that early clinical results of the first patients treated with Zimmer MotionLoc™ Screws were free of complications.  The Zimmer MotionLoc Screw is...

Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device

February 18, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 18, 2011 /- Zimmer Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a leader in musculoskeletal care, today announced it has received FDA clearance for the TM-S Trabecular Metal™ Cervical Interbody Fusion Device.  The TM-S system is the industry's first cervical interbody...

Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV

February 18, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

CORK, Ireland, Feb. 18, 2011 /- Tibotec Pharmaceuticals announced today that two global, registrational phase 3 trials are recruiting patients to examine TMC435, its investigational hepatitis C protease inhibitor, in treatment-naive adults with chronic genotype 1 hepatitis C virus (HCV)....

Golden Meditech to Form Strategic Alliance with Long Bon International

February 18, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

TAIPEI, Feb. 18, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings ("Golden Meditech," 0801.HK, 910801.TW) and Long Bon International Co., Limited ("Long Bon International") today announced that the companies have entered into a memorandum of understanding (MOU) for strategic...

Intrinsic Enrolls First Patient in Barricaid® Trial

February 17, 2011 10:32 am | by Bio-Medicine.Org | News | Comments

WOBURN, Mass., Feb. 17, 2011 /- Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its Barricaid® device. Barricaid is designed to prevent...

Success Factors and Failure Points in Biopharmaceutical Product Launches

February 17, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

CHAPEL HILL, N.C., Feb. 17, 2011 /- Recent biopharmaceutical product launches have produced both noteworthy failures and successes. Faced with a continually evolving launch landscape, organizations are rethinking the factors that play the biggest role in the current launch environment. In...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading